Friday, October 7, 2016

Retrovir


Retrovir is a brand name of zidovudine, approved by the FDA in the following formulation(s):


RETROVIR (zidovudine - capsule; oral)



  • Manufacturer: VIIV HLTHCARE

    Approval date: March 19, 1987

    Strength(s): 100MG [RLD][AB]

RETROVIR (zidovudine - injectable; injection)



  • Manufacturer: VIIV HLTHCARE

    Approval date: February 2, 1990

    Strength(s): 10MG/ML [RLD][AP]

RETROVIR (zidovudine - syrup; oral)



  • Manufacturer: VIIV HLTHCARE

    Approval date: September 28, 1989

    Strength(s): 50MG/5ML [RLD][AA]

RETROVIR (zidovudine - tablet; oral)



  • Manufacturer: VIIV HLTHCARE

    Approval date: October 4, 1996

    Strength(s): 300MG [RLD][AB]

Has a generic version of Retrovir been approved?


Yes. The following products are equivalent to Retrovir:


zidovudine capsule; oral



  • Manufacturer: AUROBINDO PHARMA LTD

    Approval date: March 27, 2006

    Strength(s): 100MG [AB]


  • Manufacturer: CIPLA LTD

    Approval date: May 23, 2007

    Strength(s): 100MG [AB]

zidovudine injectable; injection



  • Manufacturer: LUITPOLD

    Approval date: May 6, 2010

    Strength(s): 10MG/ML [AP]

zidovudine syrup; oral



  • Manufacturer: AUROBINDO

    Approval date: September 19, 2005

    Strength(s): 50MG/5ML [AA]


  • Manufacturer: CIPLA LTD

    Approval date: June 26, 2008

    Strength(s): 50MG/5ML [AA]

zidovudine tablet; oral



  • Manufacturer: AUROBINDO

    Approval date: September 19, 2005

    Strength(s): 300MG [AB]


  • Manufacturer: CIPLA

    Approval date: October 27, 2010

    Strength(s): 300MG [AB]


  • Manufacturer: HEC PHARM INC

    Approval date: October 7, 2011

    Strength(s): 300MG [AB]


  • Manufacturer: HETERO DRUGS LTD

    Approval date: April 25, 2008

    Strength(s): 300MG [AB]


  • Manufacturer: MATRIX LABS LTD

    Approval date: February 14, 2008

    Strength(s): 300MG [AB]


  • Manufacturer: RANBAXY

    Approval date: September 19, 2005

    Strength(s): 300MG [AB]


  • Manufacturer: ROXANE

    Approval date: September 19, 2005

    Strength(s): 300MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Retrovir. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Retrovir.

See also...

  • Retrovir Consumer Information (Wolters Kluwer)
  • Retrovir Capsules Consumer Information (Wolters Kluwer)
  • Retrovir Syrup Consumer Information (Wolters Kluwer)
  • Retrovir Consumer Information (Cerner Multum)
  • Retrovir injection Consumer Information (Cerner Multum)
  • Retrovir Advanced Consumer Information (Micromedex)
  • Retrovir Intravenous Advanced Consumer Information (Micromedex)
  • Retrovir AHFS DI Monographs (ASHP)
  • Zidovudine Consumer Information (Wolters Kluwer)
  • Zidovudine Capsules Consumer Information (Wolters Kluwer)
  • Zidovudine Syrup Consumer Information (Wolters Kluwer)
  • Zidovudine Consumer Information (Cerner Multum)
  • Zidovudine injection Consumer Information (Cerner Multum)
  • Zidovudine Advanced Consumer Information (Micromedex)
  • Zidovudine Intravenous Advanced Consumer Information (Micromedex)
  • Zidovudine AHFS DI Monographs (ASHP)

No comments:

Post a Comment